CHOLESTATIC LIVER DISEASE
Clinical trials for CHOLESTATIC LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHOLESTATIC LIVER DISEASE trials appear
Sign up with your email to follow new studies for CHOLESTATIC LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug study aims to understand liver disease treatment
Knowledge-focused Recruiting nowThis early-stage study looks at how the body processes the drug Saroglitazar in people with mild, moderate, or severe liver cirrhosis caused by cholestatic liver disease. About 30 adults aged 18 to 80 will take the drug once daily for 28 days. The goal is to measure drug levels a…
Matched conditions: CHOLESTATIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Zydus Therapeutics Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 04:16 UTC
-
New drug study aims to understand safety in liver patients
Knowledge-focused Recruiting nowThis early-stage study is testing a drug called saroglitazar in 6 people with moderate liver damage (cirrhosis) caused by cholestatic liver disease. The main goal is to see how the drug moves through the body and whether it is safe when taken every other day. This study does not …
Matched conditions: CHOLESTATIC LIVER DISEASE
Phase: PHASE1 • Sponsor: Zydus Therapeutics Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC
-
Can DNA testing solve mysterious liver disease in adults?
Knowledge-focused Recruiting nowThis study looks for hidden genetic causes of cholestatic liver disease in adults whose diagnosis remains unclear after standard tests. Researchers will use whole-genome sequencing to analyze DNA from 60 participants. The goal is to find rare gene changes that explain the disease…
Matched conditions: CHOLESTATIC LIVER DISEASE
Phase: NA • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC